Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR EP News Bureau May 21, 2025 Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy…
Allecra’s EXBLIFEP approval to treat cUTIs provides valuable new weapon to tackle ESBL mediated AMR:… EP News Bureau Mar 1, 2024 In addition to the FDA approval, EXBLIFEP has also been submitted for marketing approval in the EU and received a positive opinion…
US FDA approves new antibacterial drug Zerbaxa Usha Sharma Dec 22, 2014 Zerbaxa is used to treat cUTI, including kidney infection (pyelonephritis)
